Early plasma exposure after a first dose of ribavirin in HIV-HCV coinfected patients compared with HCV monoinfected patients

被引：0
|
作者：
Hatu, Giorgiana [1 ]
Pradat, Pierre [1 ]
Pourcelot, Emmanuel [2 ]
Maynard-Muet, Marianne [1 ]
Bailly, Francois [1 ]
Miailhes, Patrick [1 ]
Zoulim, Fabien [1 ]
Gagnieu, Marie-Claude [2 ]
机构：
[1] Hop Croix Rousse, Hosp Civils Lyon, F-69317 Lyon, France
[2] Hop Edouard Herriot, Hosp Civils Lyon, Lyon, France
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1917
引用
收藏
页码：1134A / 1134A
页数：1
相关论文
共 50 条
  • [41] SVR in HIV-HCV coinfected patients can be enhanced by optimizing dosing of pegylated interferon and ribavirin therapy
    Monto, Alexander
    Rodriguez, Rebecca F.
    Currie, Sue
    George, Sally
    Lee, Natalie
    Tracy, Daniel P.
    Wright, Teresa L.
    GASTROENTEROLOGY, 2007, 132 (04) : A794 - A794
  • [42] Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients
    Ramos, B.
    Nunez, M.
    Rendon, A.
    Romero, M.
    Sheldon, J.
    Barreiro, P.
    Martin-Carbonero, L.
    Moreno, A.
    Garcia-Samaniego, J.
    Soriano, V.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S213 - S213
  • [43] Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients
    Milazzo, L.
    Meroni, L.
    Galazzi, M.
    Cesari, M.
    Caramma, I.
    Marchetti, G.
    Galli, M.
    Antinori, S.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (07) : 479 - 484
  • [44] Severe mitochondrial toxicity after liver transplantation in HIV-HCV coinfected patients.
    Duclos-Vallee, JC
    Jardel, C
    Vittecoq, D
    Teicher, E
    Roche, B
    Feray, C
    Gigou, M
    Ichai, P
    Saliba, F
    Adam, R
    Azoulay, D
    Guettier, C
    Castaing, D
    Bismuth, H
    Samuel, D
    Lombes, A
    HEPATOLOGY, 2003, 38 (04) : 375A - 375A
  • [45] Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients
    Ramos, B.
    Nunez, M.
    Rendon, A.
    Berdun, M. A.
    Losada, E.
    Santos, I.
    Echevarria, S.
    Ocampo, A.
    Miralles, C.
    Arazo, P.
    Barreiro, P.
    Romero, M.
    Labarga, P.
    Guardiola, J. M.
    Garcia-Samaniego, J.
    V., Soriano
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (06) : 387 - 391
  • [46] Efficacy and tolerance of HCV treatment in HIV-HCV coinfected patients: The potential interaction of PI treatment
    Poizot-Martin, I
    Marimoutou, C
    Benhaim, S
    Drogoul-Vey, MP
    Dinh, T
    Vion-Dury, F
    Frixon-Marin, V
    Tamalet, C
    Gastaut, JA
    HIV CLINICAL TRIALS, 2003, 4 (04): : 262 - 268
  • [47] Natural history of factors influencing the severity of chronic HCV infection in HIV-HCV coinfected patients
    Roulot, Dominique
    Vallet-Pichard, Anaies
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2007, 31 (10): : 881 - 886
  • [48] Peritransplant treatment with Direct Acting Antivirals of HIV-HCV coinfected patients
    Vinaixa, Carmen
    Aguilera, Victoria
    Rubin, Angel
    Garcia, Maria
    Blanes, Marino
    Benlloch, Salvador
    Prieto, Martin
    Berenguer, Marina
    Juan, Fernando San
    HEPATOLOGY, 2016, 64 : 807A - 808A
  • [49] Baseline Plasma Metabotype Correlates With Direct-Acting Antiviral Therapy Nonresponse for HCV in HIV-HCV Coinfected Patients
    Tripathi, Gaurav
    Rooge, Sheetalnath
    Yadav, Manisha
    Mathew, Babu
    Sharma, Nupur
    Bindal, Vasundhra
    Hemati, Hamed
    Singh Maras, Jaswinder
    Gupta, Ekta
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
  • [50] Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors
    Bani-Sadr, F
    Carrat, F
    Bedossa, P
    Piroth, L
    Cacoub, P
    Perronne, C
    Degott, C
    Pol, S
    AIDS, 2006, 20 (04) : 525 - 531
12345